XT
ATRA icon

XTX Topco’s Atara Biotherapeutics ATRA Stock Holding History

XTX Topco’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,422
Closed -$18.2K – 1830
2023
Q4 		$18.2K Buy
1,422
+52
+4% +$1.21K ﹤0.01% 1370
2023
Q3 		$50.7K Sell
1,370
-4,104
-75% -$183K 0.01% 1276
2023
Q2 		$220K Buy
+5,474
New +$310K 0.04% 943
2023
Q1 		– Sell
-1,146
Closed -$94K – 1264
2022
Q4 		$94K Sell
1,146
-5,514
-83% -$575K 0.02% 1007
2022
Q3 		$629K Buy
+6,660
New +$748K 0.16% 156
2022
Q2 		– Sell
-931
Closed -$216K – 842
2022
Q1 		$216K Buy
+931
New +$296K 0.09% 382
2021
Q2 		– Sell
-423
Closed -$152K – 803
2021
Q1 		$152K Buy
+423
New +$187K 0.07% 529

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return